Aprea Therapeutics, Inc. (NASDAQ:APRE) Financings
Financings
| Raise | Date |
|---|---|
| Private placement of shares of common stock (or pre-funded warrants) with warrants Announced: about US$5.6M · US$0.89 a share · Warrants at US$0.765 · Maxim Group LLC Dealers: Maxim Group LLC (lead) Insiders: Certain insiders of the Company are among the purchasers Use of proceeds: General corporate purposes and research and development expenses | Jan 29, 2026 |
| Private placement of private placement financing Closed: US$3.1M raised · US$1.165 a share · Warrants at US$1.04 for 60 months · Maxim Group LLC Dealers: Maxim Group LLC (lead) Insiders: The CEO, the CFO and a Board member participated alongside external investors Use of proceeds: General corporate purposes and research and development expenses | Dec 18, 2025 |